Safety & Efficacy of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Recipients
Status:
Completed
Trial end date:
2019-08-23
Target enrollment:
Participant gender:
Summary
The main purpose of this research is to determine whether injecting mesenchymal precursor
cells (MPC) into the heart during surgery to implant a left ventricular assist device (LVAD)
is safe. MPCs are normally present in human bone marrow and have been shown to increase the
development of blood vessels and new heart muscle cells in the heart. In addition, this
research is being done to test whether injecting the MPCs into the heart is effective in
improving heart function.